glp-1/gip/glucagon triple agonist name Main physiological actions of the dual GIP and GLP-1 Dual and Triple Gut Peptide
Description
Agha M, Agha R

(1983b)

J Diabet Invest 7(suppl 1):812

In other CVOTs most patients received target dose (maximal tolerated dose) and no analysis was done regarding dose-dependent effects

Also approved to reduce cardiovascular risk

Melmed, S
